NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/30/2026
Back to search
Official data from USPTO
HYLIQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
05/01/2026
Trademark type
Word
Nice classes
3, 5, 42
Filing date
07/13/2021
Registration date
09/27/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/27/2022
Last transaction
05/01/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
US
Examiner
SIRIGNANO, EMMA MARIE
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Dermaliq Therapeutics Inc.
Dermaliq Therapeutics Inc.
NOVALIQ GmbH
Representatives
Barbara Guggenmos Guggenmos Rechtsanwaelte,
Technical classification
Nice Classes
Class 3Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
non-medicated skin care preparations; body cleaning and beauty care preparations in the nature of non-medicated skin treatments; sunscreen preparations; animal grooming preparations in the nature of non-medicated skin care and fur care; non-medicated gelsliquids and lotions for skin care; cosmetic preparations; cosmetic products in the nature of non-medicated preparations for skincare; cosmetic products in the form of aerosols for skin care; lipsticks; non-medicated mouthwash
Class 5
Pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the treatment of skin diseases; medicated preparations for skin treatment; disinfectants and antiseptics for use in dermatology; anti-bacterial preparations for use in dermatology; antimicrobials for dermatologic use; antiviral preparations for use in dermatology; antimycotics in the nature of antifungal preparations; antiparasitics; virostatics in the nature of antivirals; antibacterials for dermatologic use; fungicides for dermatologic use; anti-infective preparations for the skin
Class 42
Medical and pharmacological research services; scientific research for medical purposes; chemical research and analysis services; scientific laboratory services; development of pharmaceutical preparations and medicines; clinical research in the field of dermatological and infectious diseases; testingauthentication and quality control of clinical and medical research in the field of dermatologic and infectious diseases; research and development in the field of cosmetics and skin care products; research and development in the field of dermatology
Publications
History of USPTO decisions and trademark events.
41 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/14/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/25/2023
FIMP
FINAL DISPOSITION PROCESSED
01/25/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/27/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/12/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/27/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/27/2022
GPNX
NOTIFICATION PROCESSED BY IB
07/19/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/12/2022
PUBO
PUBLISHED FOR OPPOSITION
07/12/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/29/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/29/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/22/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/03/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
06/03/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/03/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
06/03/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/03/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
05/25/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
05/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/26/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
04/26/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/26/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
04/26/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/26/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
04/22/2022
RFNT
REFUSAL PROCESSED BY IB
04/18/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/31/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/30/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/30/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/23/2022
RFRR
REFUSAL PROCESSED BY MPU
03/23/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/23/2022
CNRT
NON-FINAL ACTION WRITTEN
03/22/2022
DOCK
ASSIGNED TO EXAMINER
03/22/2022
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
03/02/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
12/05/2021
MAFR
APPLICATION FILING RECEIPT MAILED
11/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/05/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/28/2021
Continuous trademark protection
Get notified about every new filing that threatens HYLIQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.